Sun Pharma Advanced Research Company Ltd share price logo

Sparc Share Price (SPARC)

Check the latest share price of Sparc, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹165.90.62%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Sparc Stock Performance

Get live Sparc share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹162.8
    Day's Price Range
    ₹167.28
  • 52 Week's Low

    52 Week's High

    ₹109.3
    52-Week Price Range
    ₹258
1 Month Return+ 10.1 %
3 Month Return+ 41.49 %
1 Year Return-29.18 %
3 Year Return-17.03 %
5 Year Return+ 13.98 %
Previous Close₹166.94
Open₹165.00
Volume7.84L
Upper Circuit₹200.32
Lower Circuit₹133.55

Sparc Fundamentals & Key Indicators

Check Sparc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹5,383.81 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-15.71

Return on capital employed (ROCE)

0

Industry PE ratio

57.39

Beta (LTM)

0

P/B Ratio

96.09

Dividend Yield

0

PEG Ratio

-11.47

Quarterly Earnings Growth YOY

-43.5

EPS (TTM)

-11.93

Sector

Pharmaceuticals

Book Value

3.88

Technical Analysis

How to invest in Sparc?

Investing in Sparc is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Sparc or SPARC on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Sparc or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Sparc with just a few clicks!

Sparc Stock's Interest Amongst Investors

359.88%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Investment in Sun Pharma Advanced Research Company Ltd Shares on INDmoney has grown by 359.88% over the past 30 days, indicating increased transactional activity.

342%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Sun Pharma Advanced Research Company Ltd Stock has increased by 342% in the last 30 days, reflecting an upward trend in search activity.

Sparc Valuation

Track how Sparc P/E has moved over time to understand its valuation trends.

Sparc in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-15.71x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (0.00x)

December 29, 2023

LowHigh

Today’s Price to Earnings Ratio: -15.71x

Sparc Financial Results

Get the annual and quarterly financial summary of Sparc, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

17 (0%)17 (2%)13 (24%)15 (16%)27 (82%)
Net Income

(in ₹ Cr)

-106 (0%)-96 (9%)-107 (12%)-80 (26%)-60 (25%)
Net Profit Margin-638.83% (0%)-570.49% (11%)-834.60% (46%)-533.27% (36%)-219.82% (59%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

230 (0%)280 (22%)830 (196%)486 (41%)
Total Liabilities

(in ₹ Cr)

398 (0%)249 (37%)317 (28%)361 (14%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-211 (0%)-152 (28%)-208 (37%)-69 (67%)-429 (521%)

Indices Featuring Sparc Stock

Check stock indices that include Sparc.

S&P BSE 250 SmallCap

₹6,870.18

-0.37 (-25.22%)

S&P BSE 400 MidSmallCap

₹12,015.06

-0.31 (-37.67%)

BSE Small-Cap

₹53,370.29

-0.3 (-161.18%)

BSE Healthcare

₹43,995.31

0.08 (34.42%)

BSE 500

₹35,946.69

-0.57 (-206.81%)

Sparc Earnings and Dividends

View detailed summary of the earnings and dividend history of Sparc.

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 43.5% since last year same period to ₹-59.77Cr in the Q4 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 24.83% jump in its net profits since last 3-months.

    Read More about Earnings Results

Sparc Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sparc.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
65.67%
0.00
Foreign Institutions
1.45%
0.00
Mutual Funds
1.01%
0.00
Retail Investors
31.75%
0.00
Others
0.12%
0.00

Sparc vs Peers

Compare market cap, revenue, PE, and other key metrics of Sparc with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA5,383.812.8%0.79-38875
BUY38,428.87101.79%0.523001,051
BUY17,430.6117.42%0.57726,702
BUY14,436.5943.15%0.682441,515
HOLD22,503.43130.52%0.552581,375

Sparc News & Key Events

Latest news and events in one place to help you make informed investing decisions in Sparc.

  • SPARC Maintains Stability Despite Trial Discontinuation - 05 Jun, 2025

    Sun Pharma Advanced Research Co. reassured investors that the discontinuation of SCD-044 trials will not impact financials. The company highlighted multiple promising assets in its pipeline, including SBO-154 and SCD-153, which are set to advance in clinical trials. SPARC anticipates stable cash flow from licensing these assets, offsetting any losses from discontinued projects.
  • SPARC Stock Plummets After Drug Trial Failures - 04 Jun, 2025

    Sun Pharma Advanced Research Company (SPARC) shares fell nearly 20% after Vibozilimod failed Phase 2 trials for psoriasis and atopic dermatitis, prompting a reevaluation of their pipeline and strategies.

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.51% to 1.01% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, SPARC stock has moved up by 41.5%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.46% to 31.75% in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 148.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 74.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.23% to 1.45% in Mar 2025 quarter

About Sparc

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Revenue: ₹27.19Cr as on March 2025 (Q4 FY25)
Net Profit: ₹-59.77Cr as on March 2025 (Q4 FY25)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEODilip S Shanghvi
E-voting on sharesClick here to vote

FAQs

What is Sparc share price today?

Sparc share price today stands at ₹165.9, Open: ₹165, Previous Close: ₹166.94, High: ₹167.28, Low: ₹162.8, 52 Week High: ₹258, 52 Week Low: ₹109.3.

What is today's traded volume of Sparc?

Today's traded volume of Sparc is 7.84L. Which means that 7.84L shares of Sparc were bought and sold on the stock market during today's trading session.

What is Sparc's market cap today?

Today's market capitalisation of Sparc is ₹5,383.81 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Sparc?

Sparc’s 52 week high is ₹258 and 52 week low is ₹109.3. The current share price of Sparc is ₹165.9, which is -35.70% down from its 52 week high and 51.78% up from its 52 week low.